

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 4.68020571 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.68020571 |
| 3 | protein localization to endosome (GO:0036010) | 4.42243909 |
| 4 | piRNA metabolic process (GO:0034587) | 4.33254241 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15399351 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.15399351 |
| 7 | regulation of female gonad development (GO:2000194) | 4.07370194 |
| 8 | barbed-end actin filament capping (GO:0051016) | 4.04863949 |
| 9 | urea metabolic process (GO:0019627) | 3.95975765 |
| 10 | urea cycle (GO:0000050) | 3.95975765 |
| 11 | virion attachment to host cell (GO:0019062) | 3.95403645 |
| 12 | adhesion of symbiont to host cell (GO:0044650) | 3.95403645 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 3.93985683 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.93985683 |
| 15 | ER overload response (GO:0006983) | 3.90363989 |
| 16 | negative regulation of sodium ion transport (GO:0010766) | 3.68096791 |
| 17 | COPII vesicle coating (GO:0048208) | 3.58725972 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 3.56573118 |
| 19 | lysine catabolic process (GO:0006554) | 3.53487484 |
| 20 | lysine metabolic process (GO:0006553) | 3.53487484 |
| 21 | negative regulation of meiosis (GO:0045835) | 3.53303361 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 3.51623184 |
| 23 | cysteine metabolic process (GO:0006534) | 3.51128102 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 3.50200956 |
| 25 | regulation of hippo signaling (GO:0035330) | 3.49286338 |
| 26 | drug catabolic process (GO:0042737) | 3.45595926 |
| 27 | snRNA transcription (GO:0009301) | 3.45365984 |
| 28 | regulation of chromatin binding (GO:0035561) | 3.45237634 |
| 29 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.44056975 |
| 30 | negative regulation of fibrinolysis (GO:0051918) | 3.42916017 |
| 31 | glycosphingolipid catabolic process (GO:0046479) | 3.37704165 |
| 32 | adhesion of symbiont to host (GO:0044406) | 3.37496762 |
| 33 | protein K6-linked ubiquitination (GO:0085020) | 3.36559797 |
| 34 | homocysteine metabolic process (GO:0050667) | 3.30551593 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 3.29195846 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.27542887 |
| 37 | glyoxylate metabolic process (GO:0046487) | 3.24060914 |
| 38 | one-carbon metabolic process (GO:0006730) | 3.21197039 |
| 39 | skin morphogenesis (GO:0043589) | 3.15861251 |
| 40 | pattern specification involved in kidney development (GO:0061004) | 3.09812213 |
| 41 | stress fiber assembly (GO:0043149) | 3.08118503 |
| 42 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.07478860 |
| 43 | mitotic metaphase plate congression (GO:0007080) | 3.07164057 |
| 44 | glycolipid catabolic process (GO:0019377) | 3.06670669 |
| 45 | protein carboxylation (GO:0018214) | 3.05532744 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.05532744 |
| 47 | tryptophan metabolic process (GO:0006568) | 3.02592601 |
| 48 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99695227 |
| 49 | tryptophan catabolic process (GO:0006569) | 2.97470253 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 2.97470253 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 2.97470253 |
| 52 | regulation of spindle organization (GO:0090224) | 2.96910429 |
| 53 | citrulline biosynthetic process (GO:0019240) | 2.96309734 |
| 54 | regulation of acrosome reaction (GO:0060046) | 2.96083926 |
| 55 | kynurenine metabolic process (GO:0070189) | 2.94784077 |
| 56 | oocyte maturation (GO:0001556) | 2.93785620 |
| 57 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93781631 |
| 58 | regulation of meiosis (GO:0040020) | 2.93221526 |
| 59 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.92535979 |
| 60 | peroxisome fission (GO:0016559) | 2.92333063 |
| 61 | oligosaccharide catabolic process (GO:0009313) | 2.92264745 |
| 62 | intestinal cholesterol absorption (GO:0030299) | 2.91535405 |
| 63 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.91222162 |
| 64 | proline biosynthetic process (GO:0006561) | 2.91165639 |
| 65 | positive regulation of nuclease activity (GO:0032075) | 2.89920941 |
| 66 | amino sugar catabolic process (GO:0046348) | 2.86255237 |
| 67 | glycine metabolic process (GO:0006544) | 2.85378001 |
| 68 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.85298617 |
| 69 | bile acid biosynthetic process (GO:0006699) | 2.83039654 |
| 70 | negative regulation of fatty acid transport (GO:2000192) | 2.82455508 |
| 71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.82121531 |
| 72 | complement activation, alternative pathway (GO:0006957) | 2.81556880 |
| 73 | type B pancreatic cell development (GO:0003323) | 2.80919749 |
| 74 | ceramide catabolic process (GO:0046514) | 2.79258578 |
| 75 | regulation of glucokinase activity (GO:0033131) | 2.77730545 |
| 76 | regulation of hexokinase activity (GO:1903299) | 2.77730545 |
| 77 | regulation of tight junction assembly (GO:2000810) | 2.76970894 |
| 78 | alpha-linolenic acid metabolic process (GO:0036109) | 2.76867363 |
| 79 | base-excision repair, AP site formation (GO:0006285) | 2.76211946 |
| 80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.75536155 |
| 81 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.75351865 |
| 82 | histone H2A monoubiquitination (GO:0035518) | 2.74568921 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.74174800 |
| 84 | sphingosine metabolic process (GO:0006670) | 2.74015249 |
| 85 | urate metabolic process (GO:0046415) | 2.72699834 |
| 86 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.72223609 |
| 87 | regulation of fibrinolysis (GO:0051917) | 2.72050242 |
| 88 | amyloid precursor protein catabolic process (GO:0042987) | 2.71946244 |
| 89 | notochord development (GO:0030903) | 2.70514224 |
| 90 | rRNA methylation (GO:0031167) | 2.69389901 |
| 91 | regulation of protein activation cascade (GO:2000257) | 2.68818633 |
| 92 | protein retention in ER lumen (GO:0006621) | 2.68262420 |
| 93 | mitochondrial calcium ion transport (GO:0006851) | 2.67580933 |
| 94 | triglyceride homeostasis (GO:0070328) | 2.67487313 |
| 95 | acylglycerol homeostasis (GO:0055090) | 2.67487313 |
| 96 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.67075319 |
| 97 | response to laminar fluid shear stress (GO:0034616) | 2.66510799 |
| 98 | gene silencing by RNA (GO:0031047) | 2.65109218 |
| 99 | high-density lipoprotein particle remodeling (GO:0034375) | 2.65064938 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64536451 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 2.64536451 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64536451 |
| 103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64536451 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64536451 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 2.64536451 |
| 106 | cellular response to unfolded protein (GO:0034620) | 2.64284672 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 2.63255495 |
| 108 | cellular response to topologically incorrect protein (GO:0035967) | 2.62911648 |
| 109 | regulation of nuclease activity (GO:0032069) | 2.62068001 |
| 110 | ER-nucleus signaling pathway (GO:0006984) | 2.61800579 |
| 111 | folic acid metabolic process (GO:0046655) | 2.61378815 |
| 112 | tyrosine metabolic process (GO:0006570) | 2.60736521 |
| 113 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.59853439 |
| 114 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.59735066 |
| 115 | serine transport (GO:0032329) | 2.59634955 |
| 116 | female gamete generation (GO:0007292) | 2.59107759 |
| 117 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.58008782 |
| 118 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.57853055 |
| 119 | citrulline metabolic process (GO:0000052) | 2.56748257 |
| 120 | peptidyl-proline hydroxylation (GO:0019511) | 2.55669102 |
| 121 | histone H2A ubiquitination (GO:0033522) | 2.54887158 |
| 122 | transcytosis (GO:0045056) | 2.54323539 |
| 123 | serine family amino acid metabolic process (GO:0009069) | 2.54087922 |
| 124 | alpha-amino acid catabolic process (GO:1901606) | 2.53877958 |
| 125 | arginine metabolic process (GO:0006525) | 2.53811623 |
| 126 | sphingolipid catabolic process (GO:0030149) | 2.52626512 |
| 127 | type B pancreatic cell proliferation (GO:0044342) | 2.51523288 |
| 128 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.51001559 |
| 129 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.50878494 |
| 130 | regulation of early endosome to late endosome transport (GO:2000641) | 2.49719760 |
| 131 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.48861281 |
| 132 | axon extension involved in axon guidance (GO:0048846) | 2.48861281 |
| 133 | intestinal absorption (GO:0050892) | 2.48858924 |
| 134 | membrane lipid catabolic process (GO:0046466) | 2.48343706 |
| 135 | regulation of extracellular matrix disassembly (GO:0010715) | 2.48033892 |
| 136 | regulation of complement activation (GO:0030449) | 2.47468639 |
| 137 | cell adhesion mediated by integrin (GO:0033627) | 2.47452930 |
| 138 | carnitine metabolic process (GO:0009437) | 2.46629610 |
| 139 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.42943351 |
| 140 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.42943351 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.42079869 |
| 142 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.41235068 |
| 143 | keratan sulfate catabolic process (GO:0042340) | 2.40432782 |
| 144 | detection of molecule of bacterial origin (GO:0032490) | 2.39913532 |
| 145 | linoleic acid metabolic process (GO:0043651) | 2.37595512 |
| 146 | protein hydroxylation (GO:0018126) | 2.37573725 |
| 147 | positive regulation of extracellular matrix organization (GO:1903055) | 2.36841491 |
| 148 | regulation of mononuclear cell migration (GO:0071675) | 2.34010952 |
| 149 | pinocytosis (GO:0006907) | 2.32500121 |
| 150 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.29320795 |
| 151 | negative regulation of interleukin-12 production (GO:0032695) | 2.29066437 |
| 152 | L-serine transport (GO:0015825) | 2.28684374 |
| 153 | fibrinolysis (GO:0042730) | 2.28374967 |
| 154 | response to peptidoglycan (GO:0032494) | 2.28013608 |
| 155 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.27458599 |
| 156 | positive regulation of receptor recycling (GO:0001921) | 2.27363080 |
| 157 | macroautophagy (GO:0016236) | 2.26250995 |
| 158 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.25468983 |
| 159 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.23805733 |
| 160 | substrate-dependent cell migration (GO:0006929) | 2.23773502 |
| 161 | epoxygenase P450 pathway (GO:0019373) | 2.23744257 |
| 162 | response to arsenic-containing substance (GO:0046685) | 2.21336335 |
| 163 | vesicle coating (GO:0006901) | 2.19380562 |
| 164 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.19216923 |
| 165 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.17756290 |
| 166 | macrophage activation involved in immune response (GO:0002281) | 2.17568276 |
| 167 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.17360155 |
| 168 | low-density lipoprotein particle clearance (GO:0034383) | 2.16456187 |
| 169 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.16379633 |
| 170 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.15820577 |
| 171 | diol metabolic process (GO:0034311) | 2.15063160 |
| 172 | cellular copper ion homeostasis (GO:0006878) | 2.14984869 |
| 173 | basement membrane organization (GO:0071711) | 2.14905117 |
| 174 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.13715690 |
| 175 | 4-hydroxyproline metabolic process (GO:0019471) | 2.12191229 |
| 176 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.12108999 |
| 177 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.11525619 |
| 178 | N-acetylneuraminate metabolic process (GO:0006054) | 2.11416390 |
| 179 | negative regulation of protein activation cascade (GO:2000258) | 2.11009629 |
| 180 | virion assembly (GO:0019068) | 2.11001946 |
| 181 | glial cell migration (GO:0008347) | 2.10623108 |
| 182 | negative regulation of glucose import (GO:0046325) | 2.07301892 |
| 183 | phospholipid efflux (GO:0033700) | 2.07282125 |
| 184 | endocytic recycling (GO:0032456) | 2.07178098 |
| 185 | regulation of plasminogen activation (GO:0010755) | 2.06978848 |
| 186 | cellular response to type I interferon (GO:0071357) | 2.06450216 |
| 187 | type I interferon signaling pathway (GO:0060337) | 2.06450216 |
| 188 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.05667406 |
| 189 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.05493782 |
| 190 | negative regulation of complement activation (GO:0045916) | 2.05169632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.89998481 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.53714513 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.36144509 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.82334083 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57180170 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.53134185 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.87871002 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.84448267 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.73438648 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.66024534 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63531901 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56127128 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52832233 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52026265 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44911938 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.36835297 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34174919 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.28704514 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27986418 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.27114412 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22555514 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16436871 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.16281749 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.14501861 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.12463519 |
| 26 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12288983 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.08934931 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.00498790 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99006997 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96788036 |
| 31 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.96239410 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93363877 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84457937 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84206689 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.82433022 |
| 36 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.81721445 |
| 37 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76352720 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.76053029 |
| 39 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.75210442 |
| 40 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.74467170 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63730830 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63229012 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62940469 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62521141 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59500924 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58087948 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.57520042 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55197231 |
| 49 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.51880522 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50294906 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50121056 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.49715525 |
| 53 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.48807290 |
| 54 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.48262840 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46155835 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43898461 |
| 57 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.43555382 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43115260 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42281016 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.41129608 |
| 61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41115925 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37796783 |
| 63 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.36234008 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35765288 |
| 65 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33834563 |
| 66 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33625521 |
| 67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31587159 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31172804 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30586193 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30485614 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29591456 |
| 72 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29431518 |
| 73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.28415064 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28303957 |
| 75 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.27828826 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27605163 |
| 77 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.26598074 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.25827012 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25333280 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25048092 |
| 81 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.24544769 |
| 82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24180064 |
| 83 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23534129 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23328548 |
| 85 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.22772322 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22173178 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22143901 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21648670 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18621412 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18568933 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18457737 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18392838 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18327795 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17624129 |
| 95 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16972744 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16297792 |
| 97 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15570413 |
| 98 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.15439294 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15061858 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14369310 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13982524 |
| 102 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.13219591 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.13169423 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.13169423 |
| 105 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13068714 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12666108 |
| 107 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12649961 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12289282 |
| 109 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11870903 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11757902 |
| 111 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11478250 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11395281 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10706423 |
| 114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10559314 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10372958 |
| 116 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09851374 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08949996 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08052957 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07231350 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07207054 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07030385 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06983259 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06983259 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05807631 |
| 125 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05613240 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05575366 |
| 127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05259073 |
| 128 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05214368 |
| 129 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05071638 |
| 130 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04731588 |
| 131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04708552 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03792740 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03727773 |
| 134 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03472503 |
| 135 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.02553599 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.99947240 |
| 137 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.99597917 |
| 138 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98719085 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98684440 |
| 140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97808430 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97676297 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97184695 |
| 143 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96967844 |
| 144 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96422322 |
| 145 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.96062387 |
| 146 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94452819 |
| 147 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94410128 |
| 148 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.93437837 |
| 149 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92545779 |
| 150 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92346724 |
| 151 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91914065 |
| 152 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.91558098 |
| 153 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91437873 |
| 154 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90369701 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89693256 |
| 156 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89035240 |
| 157 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88954380 |
| 158 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88384481 |
| 159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88184982 |
| 160 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87696104 |
| 161 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87687316 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87485013 |
| 163 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87416564 |
| 164 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86776931 |
| 165 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86518393 |
| 166 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.86005370 |
| 167 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85154720 |
| 168 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.85139882 |
| 169 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84338906 |
| 170 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83171266 |
| 171 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.82082548 |
| 172 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80903317 |
| 173 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.78529501 |
| 174 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77296251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.37772006 |
| 2 | MP0005365_abnormal_bile_salt | 4.36074994 |
| 3 | MP0005360_urolithiasis | 4.30497489 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.43894633 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.05280515 |
| 6 | MP0003303_peritoneal_inflammation | 2.85911183 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.85340348 |
| 8 | MP0003718_maternal_effect | 2.78535356 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.56890599 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.39561266 |
| 11 | MP0009840_abnormal_foam_cell | 2.33603881 |
| 12 | MP0005408_hypopigmentation | 2.23952622 |
| 13 | MP0000604_amyloidosis | 2.20732587 |
| 14 | MP0000343_altered_response_to | 2.18002346 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.14791961 |
| 16 | MP0003252_abnormal_bile_duct | 2.14339323 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.09105043 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.08602763 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.06621068 |
| 20 | MP0001958_emphysema | 2.04735935 |
| 21 | MP0003329_amyloid_beta_deposits | 1.98539690 |
| 22 | MP0003724_increased_susceptibility_to | 1.96867265 |
| 23 | MP0005083_abnormal_biliary_tract | 1.96819942 |
| 24 | MP0003436_decreased_susceptibility_to | 1.88332909 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.85044901 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.84386154 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.81810574 |
| 28 | MP0005451_abnormal_body_composition | 1.77342533 |
| 29 | MP0004233_abnormal_muscle_weight | 1.76342932 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.75734643 |
| 31 | MP0003279_aneurysm | 1.73965101 |
| 32 | MP0003646_muscle_fatigue | 1.73919376 |
| 33 | MP0003091_abnormal_cell_migration | 1.73436527 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.71939353 |
| 35 | MP0006082_CNS_inflammation | 1.71335444 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.71172940 |
| 37 | MP0005275_abnormal_skin_tensile | 1.69760831 |
| 38 | MP0005395_other_phenotype | 1.66377580 |
| 39 | MP0003941_abnormal_skin_development | 1.64821102 |
| 40 | MP0004272_abnormal_basement_membrane | 1.63728661 |
| 41 | MP0004858_abnormal_nervous_system | 1.61266906 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.59504510 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.56119804 |
| 44 | MP0003890_abnormal_embryonic-extraembry | 1.50219195 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.49536802 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.47445549 |
| 47 | MP0005332_abnormal_amino_acid | 1.46663721 |
| 48 | MP0005670_abnormal_white_adipose | 1.45322623 |
| 49 | MP0004510_myositis | 1.44133000 |
| 50 | MP0003075_altered_response_to | 1.44028638 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.43599224 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.43050433 |
| 53 | MP0001119_abnormal_female_reproductive | 1.41505756 |
| 54 | MP0001542_abnormal_bone_strength | 1.41365889 |
| 55 | MP0004947_skin_inflammation | 1.39418639 |
| 56 | MP0002419_abnormal_innate_immunity | 1.37650203 |
| 57 | MP0009785_altered_susceptibility_to | 1.37535123 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.35088099 |
| 59 | MP0002254_reproductive_system_inflammat | 1.32667252 |
| 60 | MP0003828_pulmonary_edema | 1.31811029 |
| 61 | MP0000609_abnormal_liver_physiology | 1.31040198 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.30525900 |
| 63 | MP0009764_decreased_sensitivity_to | 1.28868043 |
| 64 | MP0005248_abnormal_Harderian_gland | 1.23846338 |
| 65 | MP0005164_abnormal_response_to | 1.23834095 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.23372653 |
| 67 | MP0003077_abnormal_cell_cycle | 1.23268994 |
| 68 | MP0003699_abnormal_female_reproductive | 1.21219148 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.20808952 |
| 70 | MP0001849_ear_inflammation | 1.20698253 |
| 71 | MP0005389_reproductive_system_phenotype | 1.20049067 |
| 72 | MP0001919_abnormal_reproductive_system | 1.18658808 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 1.18104271 |
| 74 | MP0002796_impaired_skin_barrier | 1.17394479 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.16518626 |
| 76 | MP0000920_abnormal_myelination | 1.16458449 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.15924405 |
| 78 | MP0005646_abnormal_pituitary_gland | 1.15078473 |
| 79 | MP0003123_paternal_imprinting | 1.13378644 |
| 80 | MP0005171_absent_coat_pigmentation | 1.10810038 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.09817131 |
| 82 | MP0003943_abnormal_hepatobiliary_system | 1.09686980 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.08580340 |
| 84 | MP0009672_abnormal_birth_weight | 1.07321994 |
| 85 | MP0003942_abnormal_urinary_system | 1.06416964 |
| 86 | MP0009697_abnormal_copulation | 1.06335318 |
| 87 | MP0000371_diluted_coat_color | 1.05770079 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 1.04668062 |
| 89 | MP0006054_spinal_hemorrhage | 1.04498844 |
| 90 | MP0003868_abnormal_feces_composition | 1.04492911 |
| 91 | MP0005501_abnormal_skin_physiology | 1.04114644 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 1.03877609 |
| 93 | MP0001730_embryonic_growth_arrest | 1.03129698 |
| 94 | MP0008007_abnormal_cellular_replicative | 1.03097616 |
| 95 | MP0005380_embryogenesis_phenotype | 1.02342682 |
| 96 | MP0001672_abnormal_embryogenesis/_devel | 1.02342682 |
| 97 | MP0005025_abnormal_response_to | 1.02036068 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 1.01675157 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 1.01362103 |
| 100 | MP0000598_abnormal_liver_morphology | 1.01244031 |
| 101 | MP0004957_abnormal_blastocyst_morpholog | 1.01187401 |
| 102 | MP0000858_altered_metastatic_potential | 1.00281221 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.99449052 |
| 104 | MP0003111_abnormal_nucleus_morphology | 0.99001831 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.98675062 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.98506477 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.98035285 |
| 108 | MP0003448_altered_tumor_morphology | 0.96371751 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.96337919 |
| 110 | MP0005166_decreased_susceptibility_to | 0.95819771 |
| 111 | MP0008260_abnormal_autophagy | 0.94841358 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.94356532 |
| 113 | MP0000653_abnormal_sex_gland | 0.92953583 |
| 114 | MP0005409_darkened_coat_color | 0.92925384 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.92619059 |
| 116 | MP0003195_calcinosis | 0.92238882 |
| 117 | MP0008469_abnormal_protein_level | 0.91416906 |
| 118 | MP0003984_embryonic_growth_retardation | 0.90918247 |
| 119 | MP0001697_abnormal_embryo_size | 0.90762020 |
| 120 | MP0000685_abnormal_immune_system | 0.89929045 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89368665 |
| 122 | MP0001915_intracranial_hemorrhage | 0.87279913 |
| 123 | MP0009053_abnormal_anal_canal | 0.86642931 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.86625371 |
| 125 | MP0005187_abnormal_penis_morphology | 0.86471150 |
| 126 | MP0001756_abnormal_urination | 0.86286927 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.85037853 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84738924 |
| 129 | MP0008789_abnormal_olfactory_epithelium | 0.83768990 |
| 130 | MP0000350_abnormal_cell_proliferation | 0.82837282 |
| 131 | MP0008004_abnormal_stomach_pH | 0.82732856 |
| 132 | MP0003634_abnormal_glial_cell | 0.82416725 |
| 133 | MP0001929_abnormal_gametogenesis | 0.82178155 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.82117719 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.82055670 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.81773922 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.81498444 |
| 138 | MP0002160_abnormal_reproductive_system | 0.81426749 |
| 139 | MP0003937_abnormal_limbs/digits/tail_de | 0.79945350 |
| 140 | MP0002168_other_aberrant_phenotype | 0.79507072 |
| 141 | MP0003690_abnormal_glial_cell | 0.78848345 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.78808642 |
| 143 | MP0002127_abnormal_cardiovascular_syste | 0.78477140 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.78073725 |
| 145 | MP0003011_delayed_dark_adaptation | 0.77554797 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.77203643 |
| 147 | MP0005000_abnormal_immune_tolerance | 0.76580899 |
| 148 | MP0001216_abnormal_epidermal_layer | 0.76020464 |
| 149 | MP0008877_abnormal_DNA_methylation | 0.76017003 |
| 150 | MP0005390_skeleton_phenotype | 0.74861811 |
| 151 | MP0009703_decreased_birth_body | 0.73702193 |
| 152 | MP0003879_abnormal_hair_cell | 0.73053171 |
| 153 | MP0005595_abnormal_vascular_smooth | 0.73037648 |
| 154 | MP0004883_abnormal_blood_vessel | 0.71379587 |
| 155 | MP0003119_abnormal_digestive_system | 0.70580922 |
| 156 | MP0005023_abnormal_wound_healing | 0.70002044 |
| 157 | MP0002210_abnormal_sex_determination | 0.69957848 |
| 158 | MP0008874_decreased_physiological_sensi | 0.69184483 |
| 159 | MP0000467_abnormal_esophagus_morphology | 0.69144903 |
| 160 | MP0005197_abnormal_uvea_morphology | 0.68915501 |
| 161 | MP0002084_abnormal_developmental_patter | 0.68776548 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.68220864 |
| 163 | MP0000751_myopathy | 0.67218614 |
| 164 | MP0005623_abnormal_meninges_morphology | 0.67176489 |
| 165 | MP0003950_abnormal_plasma_membrane | 0.66618156 |
| 166 | MP0002135_abnormal_kidney_morphology | 0.66226268 |
| 167 | MP0000759_abnormal_skeletal_muscle | 0.65848367 |
| 168 | MP0005266_abnormal_metabolism | 0.65584918 |
| 169 | MP0000750_abnormal_muscle_regeneration | 0.64888264 |
| 170 | MP0001243_abnormal_dermal_layer | 0.64724005 |
| 171 | MP0002060_abnormal_skin_morphology | 0.64396675 |
| 172 | MP0005165_increased_susceptibility_to | 0.64255741 |
| 173 | MP0005503_abnormal_tendon_morphology | 0.64055295 |
| 174 | MP0002971_abnormal_brown_adipose | 0.63154040 |
| 175 | MP0005464_abnormal_platelet_physiology | 0.61894702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Male infertility (HP:0003251) | 5.15053350 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.06342211 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.81415438 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.81415438 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.81415438 |
| 6 | Gout (HP:0001997) | 4.32734157 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.06195192 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.83404281 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.83367343 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 3.80116495 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.70042750 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59358600 |
| 13 | Protrusio acetabuli (HP:0003179) | 3.47469967 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.44919969 |
| 15 | Cervical subluxation (HP:0003308) | 3.41645956 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41126163 |
| 17 | Cortical dysplasia (HP:0002539) | 3.38471209 |
| 18 | Hyperglycinemia (HP:0002154) | 3.33797969 |
| 19 | Mitral stenosis (HP:0001718) | 3.29783549 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.27593725 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23098697 |
| 22 | Premature rupture of membranes (HP:0001788) | 3.22946199 |
| 23 | Hyperglycemia (HP:0003074) | 3.19606861 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.15644709 |
| 25 | Shawl scrotum (HP:0000049) | 3.13530302 |
| 26 | Hyperammonemia (HP:0001987) | 3.08051144 |
| 27 | Hyperglycinuria (HP:0003108) | 2.97779518 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.94383993 |
| 29 | Dysostosis multiplex (HP:0000943) | 2.93200469 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92655040 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92655040 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92655040 |
| 33 | Loss of speech (HP:0002371) | 2.92203891 |
| 34 | Hypolipoproteinemia (HP:0010981) | 2.92008226 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 2.90175332 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 2.89890394 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.84380263 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84380263 |
| 39 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.83408097 |
| 40 | Xanthomatosis (HP:0000991) | 2.81030016 |
| 41 | Complement deficiency (HP:0004431) | 2.78804624 |
| 42 | Flat capital femoral epiphysis (HP:0003370) | 2.78082670 |
| 43 | Increased purine levels (HP:0004368) | 2.72633111 |
| 44 | Hyperuricemia (HP:0002149) | 2.72633111 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.72614335 |
| 46 | Ketosis (HP:0001946) | 2.70508166 |
| 47 | Failure to thrive in infancy (HP:0001531) | 2.69487109 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.67038643 |
| 49 | Palpitations (HP:0001962) | 2.66206628 |
| 50 | Nuclear cataract (HP:0100018) | 2.64035462 |
| 51 | Enlarged kidneys (HP:0000105) | 2.62426124 |
| 52 | Axonal loss (HP:0003447) | 2.62391158 |
| 53 | Hyperlipoproteinemia (HP:0010980) | 2.61427142 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.53861593 |
| 55 | Cholecystitis (HP:0001082) | 2.53861593 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.50931110 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.50931110 |
| 58 | Complete atrioventricular canal defect (HP:0001674) | 2.50875669 |
| 59 | Prolonged partial thromboplastin time (HP:0003645) | 2.50496490 |
| 60 | Papillary thyroid carcinoma (HP:0002895) | 2.50019801 |
| 61 | Ketoacidosis (HP:0001993) | 2.49423934 |
| 62 | Fat malabsorption (HP:0002630) | 2.49038720 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.48319870 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.43804981 |
| 65 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.43572995 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.42092040 |
| 67 | Insulin resistance (HP:0000855) | 2.40662484 |
| 68 | Spinal rigidity (HP:0003306) | 2.37632814 |
| 69 | Ankle contracture (HP:0006466) | 2.35774398 |
| 70 | Malnutrition (HP:0004395) | 2.33780067 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 2.33306400 |
| 72 | Poor coordination (HP:0002370) | 2.28043135 |
| 73 | Abnormality of lateral ventricle (HP:0030047) | 2.27217515 |
| 74 | Prolonged neonatal jaundice (HP:0006579) | 2.22447334 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.20447780 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20409751 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.18708670 |
| 78 | Chorioretinal atrophy (HP:0000533) | 2.17643507 |
| 79 | Ovoid vertebral bodies (HP:0003300) | 2.16765810 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.15042197 |
| 81 | Joint hemorrhage (HP:0005261) | 2.14767005 |
| 82 | Vascular tortuosity (HP:0004948) | 2.13952289 |
| 83 | Purpura (HP:0000979) | 2.13692060 |
| 84 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11049789 |
| 85 | Premature ovarian failure (HP:0008209) | 2.09069170 |
| 86 | Abnormal pancreas size (HP:0012094) | 2.07904124 |
| 87 | Hypothermia (HP:0002045) | 2.07891683 |
| 88 | Hand muscle atrophy (HP:0009130) | 2.05059024 |
| 89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03540053 |
| 90 | Lymphangioma (HP:0100764) | 2.03230572 |
| 91 | Wrist flexion contracture (HP:0001239) | 2.02558431 |
| 92 | Glomerulonephritis (HP:0000099) | 2.01580570 |
| 93 | Distal upper limb amyotrophy (HP:0007149) | 2.01014369 |
| 94 | Upper limb amyotrophy (HP:0009129) | 2.01014369 |
| 95 | Delayed puberty (HP:0000823) | 2.00270873 |
| 96 | Right ventricular cardiomyopathy (HP:0011663) | 2.00126918 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 1.99517388 |
| 98 | Late onset (HP:0003584) | 1.98945869 |
| 99 | Secondary amenorrhea (HP:0000869) | 1.98644181 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.97582059 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95863569 |
| 102 | Cystic hygroma (HP:0000476) | 1.94947066 |
| 103 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.94886287 |
| 104 | Hypoglycemic coma (HP:0001325) | 1.93574597 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.91499102 |
| 106 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.91151997 |
| 107 | Patellar aplasia (HP:0006443) | 1.90760859 |
| 108 | Arterial tortuosity (HP:0005116) | 1.90434467 |
| 109 | Genu recurvatum (HP:0002816) | 1.90386610 |
| 110 | Aortic aneurysm (HP:0004942) | 1.88763240 |
| 111 | Amyloidosis (HP:0011034) | 1.88019888 |
| 112 | Hepatocellular carcinoma (HP:0001402) | 1.87885925 |
| 113 | Exocrine pancreatic insufficiency (HP:0001738) | 1.87508052 |
| 114 | Infertility (HP:0000789) | 1.87371080 |
| 115 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87199025 |
| 116 | Myocardial infarction (HP:0001658) | 1.87128302 |
| 117 | Abnormality of complement system (HP:0005339) | 1.86680235 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86115664 |
| 119 | Diminished motivation (HP:0000745) | 1.85846225 |
| 120 | Supranuclear gaze palsy (HP:0000605) | 1.85642056 |
| 121 | Multiple lipomas (HP:0001012) | 1.84165934 |
| 122 | Apathy (HP:0000741) | 1.83545922 |
| 123 | Peripheral hypomyelination (HP:0007182) | 1.82406901 |
| 124 | Aortic dissection (HP:0002647) | 1.81063877 |
| 125 | Albinism (HP:0001022) | 1.80758308 |
| 126 | Peritonitis (HP:0002586) | 1.80551658 |
| 127 | Abnormality of the lower motor neuron (HP:0002366) | 1.80292943 |
| 128 | Orchitis (HP:0100796) | 1.80149525 |
| 129 | Steatorrhea (HP:0002570) | 1.78681830 |
| 130 | Birth length less than 3rd percentile (HP:0003561) | 1.78217869 |
| 131 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78034130 |
| 132 | Hyperextensible skin (HP:0000974) | 1.76852153 |
| 133 | Joint stiffness (HP:0001387) | 1.76499044 |
| 134 | Neoplasm of the adrenal gland (HP:0100631) | 1.76445055 |
| 135 | Long toe (HP:0010511) | 1.76139790 |
| 136 | Neonatal onset (HP:0003623) | 1.75964194 |
| 137 | Hypoplasia of the iris (HP:0007676) | 1.75293434 |
| 138 | Peripheral demyelination (HP:0011096) | 1.75111067 |
| 139 | Blue sclerae (HP:0000592) | 1.74678657 |
| 140 | Atrophic scars (HP:0001075) | 1.73426004 |
| 141 | Wormian bones (HP:0002645) | 1.72435926 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 1.71521100 |
| 143 | Hypochromic microcytic anemia (HP:0004840) | 1.70957972 |
| 144 | Slender build (HP:0001533) | 1.70934662 |
| 145 | Hepatoblastoma (HP:0002884) | 1.70424795 |
| 146 | Cardiovascular calcification (HP:0011915) | 1.69859714 |
| 147 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69478514 |
| 148 | Hypoplasia of the fovea (HP:0007750) | 1.69478514 |
| 149 | Capillary hemangiomas (HP:0005306) | 1.68579722 |
| 150 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.68221929 |
| 151 | Muscle fibrillation (HP:0010546) | 1.68201135 |
| 152 | Aortic valve stenosis (HP:0001650) | 1.68090031 |
| 153 | Upper motor neuron abnormality (HP:0002127) | 1.67195714 |
| 154 | Thin bony cortex (HP:0002753) | 1.67044412 |
| 155 | Tongue fasciculations (HP:0001308) | 1.66487933 |
| 156 | Chronic hepatic failure (HP:0100626) | 1.66469734 |
| 157 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.66351033 |
| 158 | Adrenal hypoplasia (HP:0000835) | 1.65853924 |
| 159 | Hyperparathyroidism (HP:0000843) | 1.65589325 |
| 160 | Increased IgE level (HP:0003212) | 1.65389702 |
| 161 | Elevated alkaline phosphatase (HP:0003155) | 1.65386944 |
| 162 | Thickened nuchal skin fold (HP:0000474) | 1.65142322 |
| 163 | Skin nodule (HP:0200036) | 1.64964378 |
| 164 | Metabolic acidosis (HP:0001942) | 1.64143986 |
| 165 | Proximal tubulopathy (HP:0000114) | 1.64063893 |
| 166 | Mitral regurgitation (HP:0001653) | 1.63879031 |
| 167 | Atrioventricular canal defect (HP:0006695) | 1.63668384 |
| 168 | Neonatal hypoglycemia (HP:0001998) | 1.63546592 |
| 169 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.63473629 |
| 170 | Abnormality of carpal bone ossification (HP:0006257) | 1.63427118 |
| 171 | Dilatation of the ascending aorta (HP:0005111) | 1.62279288 |
| 172 | Myositis (HP:0100614) | 1.61940248 |
| 173 | Bladder diverticulum (HP:0000015) | 1.61748605 |
| 174 | Hammertoe (HP:0001765) | 1.61451576 |
| 175 | Aneurysm (HP:0002617) | 1.61369430 |
| 176 | Increased connective tissue (HP:0009025) | 1.61343660 |
| 177 | Follicular hyperkeratosis (HP:0007502) | 1.60652066 |
| 178 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.59962544 |
| 179 | Cardiomegaly (HP:0001640) | 1.59929738 |
| 180 | Neoplasm of the adrenal cortex (HP:0100641) | 1.59799094 |
| 181 | Bone pain (HP:0002653) | 1.58855336 |
| 182 | Emphysema (HP:0002097) | 1.57222363 |
| 183 | Aortic regurgitation (HP:0001659) | 1.56202506 |
| 184 | Sensorimotor neuropathy (HP:0007141) | 1.55697303 |
| 185 | Cerebral aneurysm (HP:0004944) | 1.55507818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.46173087 |
| 2 | STK38L | 3.78401808 |
| 3 | MAP3K6 | 3.38309115 |
| 4 | LATS2 | 3.12085734 |
| 5 | ERN1 | 3.08359409 |
| 6 | PIM2 | 2.83361238 |
| 7 | AKT3 | 2.82962416 |
| 8 | BRAF | 2.61839475 |
| 9 | RIPK1 | 2.61049499 |
| 10 | EPHB1 | 2.55278914 |
| 11 | IRAK3 | 2.47768969 |
| 12 | DDR2 | 2.40538866 |
| 13 | ERBB4 | 2.38704735 |
| 14 | BRD4 | 2.37080197 |
| 15 | TRIB3 | 2.28983765 |
| 16 | NEK9 | 2.24272810 |
| 17 | TAOK3 | 2.14475682 |
| 18 | SGK2 | 2.10185058 |
| 19 | MAPKAPK3 | 2.08054428 |
| 20 | PLK4 | 2.02951544 |
| 21 | DYRK1B | 1.88490365 |
| 22 | TTK | 1.87974533 |
| 23 | ARAF | 1.87107832 |
| 24 | PDK2 | 1.82105315 |
| 25 | SGK3 | 1.80195815 |
| 26 | TBK1 | 1.76145830 |
| 27 | BCKDK | 1.74653977 |
| 28 | FRK | 1.67072364 |
| 29 | EEF2K | 1.65598338 |
| 30 | TESK1 | 1.64887515 |
| 31 | KSR2 | 1.58934426 |
| 32 | CDK8 | 1.55966061 |
| 33 | FGFR4 | 1.48793416 |
| 34 | PRKD2 | 1.42948842 |
| 35 | MAP3K4 | 1.41285110 |
| 36 | MOS | 1.40059144 |
| 37 | EPHA3 | 1.39042356 |
| 38 | SGK223 | 1.35641878 |
| 39 | SGK494 | 1.35641878 |
| 40 | PAK4 | 1.31762846 |
| 41 | PDGFRA | 1.29531389 |
| 42 | TIE1 | 1.27892241 |
| 43 | EPHB2 | 1.27172621 |
| 44 | BMPR2 | 1.23827977 |
| 45 | MYLK | 1.21509463 |
| 46 | STK3 | 1.18107544 |
| 47 | MELK | 1.15975211 |
| 48 | ICK | 1.14085660 |
| 49 | SIK1 | 1.12517760 |
| 50 | CDC42BPA | 1.10809085 |
| 51 | FGR | 1.08669976 |
| 52 | MAP3K1 | 1.08469295 |
| 53 | DAPK2 | 1.08116979 |
| 54 | MAP3K11 | 1.07859725 |
| 55 | DYRK2 | 1.06937829 |
| 56 | CCNB1 | 1.02769794 |
| 57 | BLK | 1.01994105 |
| 58 | TGFBR1 | 0.99194381 |
| 59 | MAP3K14 | 0.97960683 |
| 60 | DAPK3 | 0.97580837 |
| 61 | TYRO3 | 0.95810742 |
| 62 | CDK9 | 0.95635206 |
| 63 | MAP2K4 | 0.95219407 |
| 64 | PDK3 | 0.94865708 |
| 65 | PDK4 | 0.94865708 |
| 66 | PRKD3 | 0.94736461 |
| 67 | EPHA2 | 0.94402295 |
| 68 | SMG1 | 0.93261586 |
| 69 | TAOK1 | 0.92561413 |
| 70 | JAK1 | 0.91567511 |
| 71 | IRAK4 | 0.90624243 |
| 72 | TESK2 | 0.89536908 |
| 73 | PLK1 | 0.88866696 |
| 74 | FGFR2 | 0.88330637 |
| 75 | PAK6 | 0.86392452 |
| 76 | TGFBR2 | 0.84678247 |
| 77 | MAP3K5 | 0.83678543 |
| 78 | KSR1 | 0.83568054 |
| 79 | NME2 | 0.80624532 |
| 80 | MAPK13 | 0.79023647 |
| 81 | CSK | 0.78786134 |
| 82 | TRIM28 | 0.77765670 |
| 83 | MAP3K3 | 0.76989853 |
| 84 | PTK2 | 0.76566311 |
| 85 | MAP2K1 | 0.74636794 |
| 86 | SCYL2 | 0.74094310 |
| 87 | MARK2 | 0.73932479 |
| 88 | MAP3K9 | 0.73054718 |
| 89 | NEK1 | 0.72799622 |
| 90 | CHEK2 | 0.72351694 |
| 91 | ZAP70 | 0.72113769 |
| 92 | INSRR | 0.69142211 |
| 93 | MAP3K13 | 0.68983987 |
| 94 | KDR | 0.68525444 |
| 95 | TRPM7 | 0.66719423 |
| 96 | MATK | 0.66408411 |
| 97 | MAP2K7 | 0.66346701 |
| 98 | PINK1 | 0.64599794 |
| 99 | MTOR | 0.64360127 |
| 100 | PKN2 | 0.63849594 |
| 101 | GRK7 | 0.63517817 |
| 102 | LIMK1 | 0.63337640 |
| 103 | AURKA | 0.62655564 |
| 104 | CDK12 | 0.61294903 |
| 105 | MARK1 | 0.60680268 |
| 106 | STK38 | 0.60561916 |
| 107 | TTN | 0.60202666 |
| 108 | BCR | 0.58395919 |
| 109 | ROCK2 | 0.57234699 |
| 110 | RET | 0.57074482 |
| 111 | RAF1 | 0.56451314 |
| 112 | MET | 0.55567236 |
| 113 | PRKAA1 | 0.54647602 |
| 114 | CDK6 | 0.54290373 |
| 115 | PLK3 | 0.54205868 |
| 116 | NTRK2 | 0.53614981 |
| 117 | RPS6KA2 | 0.53044858 |
| 118 | STK24 | 0.52275299 |
| 119 | RPS6KA4 | 0.52265203 |
| 120 | NUAK1 | 0.51938207 |
| 121 | SRPK1 | 0.51936890 |
| 122 | CSNK1A1L | 0.51713853 |
| 123 | LRRK2 | 0.51696754 |
| 124 | JAK3 | 0.51692967 |
| 125 | STK10 | 0.51431160 |
| 126 | IKBKE | 0.50887951 |
| 127 | MAPKAPK2 | 0.49985169 |
| 128 | FGFR3 | 0.49088716 |
| 129 | PRKG2 | 0.48878947 |
| 130 | RPS6KC1 | 0.48301688 |
| 131 | RPS6KL1 | 0.48301688 |
| 132 | ABL2 | 0.47570415 |
| 133 | PAK2 | 0.46937890 |
| 134 | PRKAA2 | 0.46140859 |
| 135 | NEK2 | 0.45766886 |
| 136 | SIK3 | 0.43011863 |
| 137 | TYK2 | 0.42285714 |
| 138 | JAK2 | 0.41622129 |
| 139 | YES1 | 0.40451925 |
| 140 | NEK6 | 0.40132298 |
| 141 | LMTK2 | 0.39577032 |
| 142 | GSK3A | 0.38526287 |
| 143 | PDGFRB | 0.38219658 |
| 144 | MAPK7 | 0.37564940 |
| 145 | PTK6 | 0.36279928 |
| 146 | CSNK1G3 | 0.36020298 |
| 147 | MAP3K8 | 0.35749267 |
| 148 | TAOK2 | 0.35447988 |
| 149 | PDK1 | 0.35370474 |
| 150 | MAPKAPK5 | 0.35312263 |
| 151 | MAP2K3 | 0.33601306 |
| 152 | BUB1 | 0.33038366 |
| 153 | PRPF4B | 0.32380849 |
| 154 | MAPK11 | 0.29270528 |
| 155 | BMPR1B | 0.26315055 |
| 156 | FER | 0.25216176 |
| 157 | PDPK1 | 0.23868903 |
| 158 | EIF2AK1 | 0.22277183 |
| 159 | DAPK1 | 0.21325876 |
| 160 | RPS6KB1 | 0.21110763 |
| 161 | MUSK | 0.20897895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41830456 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.12378287 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.63802940 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40577176 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39652198 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32949893 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28672063 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18692955 |
| 9 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.17498024 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.16055051 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.05940859 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03214943 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02192443 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.99351361 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90559813 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88827193 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87445099 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81992889 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77248032 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76091746 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75490284 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71432821 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65598008 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65516077 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62446653 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56990799 |
| 27 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.54662755 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.53868415 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53825870 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50261553 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49700708 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49537470 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.47738207 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46384182 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45770048 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42371703 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37319180 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37266299 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35747609 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.35220493 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.34161476 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33239641 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.25527634 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.24739679 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23775879 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23578889 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20576766 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19949846 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14883385 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11751153 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11671568 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10922537 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.08771767 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.07262306 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.05874346 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04920262 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04888129 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04429425 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01231708 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00562105 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00126247 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99756488 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99281118 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99011433 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.98353146 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97933803 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96983141 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95965634 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93961062 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93433819 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91006825 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90048653 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88825177 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.88762910 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88746962 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.88739658 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.88304768 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87934670 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.87067598 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.86327908 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.86182981 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85266130 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85084492 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84725494 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82263336 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81909227 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81813001 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78584879 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78576972 |
| 90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77731354 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.76462014 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.76421763 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76368891 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76088495 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74841746 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.74794439 |
| 97 | Measles_Homo sapiens_hsa05162 | 0.74411919 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.73996783 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.73533222 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72774661 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72416003 |
| 102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71565900 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71223290 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70833596 |
| 105 | RNA transport_Homo sapiens_hsa03013 | 0.70137434 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67876721 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67453348 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66988184 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66236082 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66059999 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65712117 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63172765 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63118644 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63055564 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62932144 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.62656488 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62396193 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62218546 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.58768398 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58557380 |
| 121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57862505 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57511591 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55474429 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53492372 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53205245 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53071363 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52066139 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51943576 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51372313 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51346571 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49183090 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47595595 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47138489 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47046259 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.46953746 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.46252121 |
| 137 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45021217 |
| 138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44999557 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44785971 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44420778 |
| 141 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44271445 |
| 142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43533108 |
| 143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42710775 |
| 144 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42490221 |
| 145 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42140510 |
| 146 | Glioma_Homo sapiens_hsa05214 | 0.42046126 |
| 147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41939051 |
| 148 | Adherens junction_Homo sapiens_hsa04520 | 0.40170486 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.38947469 |
| 150 | Lysosome_Homo sapiens_hsa04142 | 0.38601239 |
| 151 | Prostate cancer_Homo sapiens_hsa05215 | 0.38559753 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37863964 |
| 153 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35110222 |
| 154 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34444997 |
| 155 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32738137 |
| 156 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32606114 |
| 157 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31835750 |

